Souhaitez-vous accéder aux communiqués récents ?

Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, today announces it has completed the acquisition of Integrity Orthopaedics, further strengthening its sports medicine shoulder...

Millburn, NJ, Jan. 21, 2026 (GLOBE NEWSWIRE) -- The Partnership for a Drug-Free New Jersey (PDFNJ) invites New Jersey business leaders to its 26th annual members webinar, “What Does Being a...

“Medical Travel Month” January 2026 Sponsored by MTDHN in SHSMD American Hospital Association’s Calendar of Health Observances

Wayne, PA, Jan. 21, 2026 (GLOBE NEWSWIRE) -- TekniPlex Healthcare, which utilizes advanced materials science expertise to help deliver better patient outcomes, will showcase its interventional and...

Designed for secondary use of multimodal, longitudinal patient data, PJI embeds regulatory-grade governance and transparency into every patient journey.

Dental expert Dr. Marvin Chan, DMD, AFAAID, FICOI of Advanced Restorative Solutions explains what dental implants are and how they replace a missing tooth.

Delray Beach, FL, Jan. 21, 2026 (GLOBE NEWSWIRE) -- In terms of value, the Carboxymethyl Cellulose Market is projected to grow from USD 3.28 billion in 2025 and to reach USD 5.04 billion by 2030, at...

Grand Cayman, Cayman Island, Jan. 21, 2026 (GLOBE NEWSWIRE) -- Silexion Therapeutics Corp. (“Silexion” or the “Company”), a clinical-stage, oncology-focused biotechnology company, today announced...

Market growth is fueled by rising R&D investments, increasing trial complexity, and demand for faster, more cost-effective drug development.

The Phase 1 clinical study of FAP-Exd (AVA6103) is anticipated to begin later in Q1 2026 LONDON and PHILADELPHIA, Jan. 21, 2026 (GLOBE NEWSWIRE) -- Avacta Therapeutics (AIM: AVCT, “the Company”,...